JPRN-jRCT2031230469尚未招募2 期
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.
Kudo Katsuyasu0 个研究点目标入组 400 人开始时间: 2023年11月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 40age old 至 <= 85age old（—）
- 性别
- All
入选标准
- •Male or female aged 40 to 85 years at the time of informed consent.
- •-Patient meets American College of Rheumatology Criteria (ACR) for Osteoarthritis of the knee
- •-Patient who fully understands the contents of the study and is competent to give consent.
排除标准
- •-Patient has renal, hepatic, cardiac, pancreatic, or metabolic diseases or hematologic abnormality.
- •-Patient is on a current treatment for malignancy or has a history of malignancy within the past 5 years.
- •-Patient who are pregnant or may be pregnant, who wants to be pregnant during the trial period, patients who are nursing. Patient who cannot agree on proper contraception in the patient or the patient's female partner is a pregnant woman.
研究者
相似试验
已完成
2 期
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.JPRN-jRCT2080224985Asahi Kasei Pharma Corporation400
已完成
2 期
Randomized, Double-Blind Study of AK1830 in Patients with low back paiow back painJPRN-jRCT2080225352Asahi Kasei Pharma Corporation400
已完成
2 期
Follow ups of patients in AK1830 Phase II Studiesosteoarthritis, chronic lumbar painJPRN-jRCT2031210566Kudo Katsuyasu10
已完成
1 期
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)JPRN-jRCT2051200119Shimizu Tomohito20
已完成
1 期
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)JPRN-jRCT2051200123Shimizu Tomohito40